Skip to content

Lung-protective ventilation Strategy during general anesthesia for the patients from Tibetan Plateau

Lung-protective ventilation Strategy during general anesthesia for the patients from Tibetan Plateau

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039835
Enrollment
Unknown
Registered
2020-11-11
Start date
2020-10-20
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

general anesthesia

Interventions

Protective Group:PEEP combined with recruitment maneuver
Conventional Group:Conventional ventilation

Sponsors

Hospital of Chengdu office of People's Government of Tibetan Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Selective general anesthesia with expected operation time >= 1h; 2. Tibetan patients living in Tibetan Plateau more than three generations, entering the plain = 18 years; 4. American Society of Anesthesiologists (ASA) II-III.

Exclusion criteria

Exclusion criteria: 1. Those who are participating in other clinical trials or do not agree to participate the clinical trials; 2. Surgery requiring single lung ventilation, prone position and lateral position; 3. General anesthesia surgery within 30 days, and invasive and / or non-invasive mechanical ventilation time >= 30min within 30 days; 4. History of lung surgery; 5. History of severe lung diseases, including severe obstructive pulmonary disease (chronic obstructive pulmonary disease) COPD), acute exacerbation of COPD, lung infections, bronchial asthma, bronchiectasis, etc .; 6. History of thoracic or intrathoracic diseases, including thoracic deformities, mediastinal tumors, chest tumors, etc .; 7. Hemodynamic instability (mean arterial pressure MAP <= 60mmHg cannot be corrected by fluid replacement and vasoactive drugs), refractory shock, acute coronary syndrome, New York Heart Association Heart Function ,NYHA) III- IV; 8. Female during pregnancy.

Design outcomes

Primary

MeasureTime frame
postoperative pulmonary complications ;

Countries

China

Contacts

Public ContactShang Kaixi

Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region

shang_2310@163.com+86 15928855368

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026